Bianchi L, Volpato S. Muscle dysfunction in type 2 diabetes: a major threat to patient’s mobility and independence. Acta Diabetol. 2016;53(6):879–89.
2.Balkhi B, Alwhaibi M, Alqahtani N, Alhawassi T, Alshammari TM, Mahmoud M, et al. Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia. BMJ Open. 2019;9(7):e029280.
3.Funck-Brentano T, Nethander M, Movérare-Skrtic S, Richette P, Ohlsson C. Causal factors for knee, hip and hand osteoarthritis: a Mendelian randomization study in the UK Biobank. Arthritis Rheumatol. 2019;71(10):1634–41.
4.Skou ST, Pedersen BK, Abbott JH, Patterson B, Barton C. Physical activity and exercise therapy benefit more than just symptoms and impairments in people with hip and knee. Osteoarthritis J Orthop Sports Phys Ther. 2018;48(6):439–47.
5.Thomas S, Browne H, Mobasheri A, Rayman MP. What is the evidence for a role for diet and nutrition in osteoarthritis? Rheumatology. 2018;57(suppl_4):iv61–74.
6.Alenazi AM, Alothman S, Alshehri MM, Rucker J, Waitman LR, Wick J, et al. The prevalence of type 2 diabetes and associated risk factors with generalized osteoarthritis: a retrospective study using ICD codes for clinical data repository system. Clin Rheumatol. 2019:1–9.
7.Bi J, Cai W, Ma T, Deng A, Ma P, Han Y, et al. Protective effect of vildagliptin on TNF-α-induced chondrocyte senescence. IUBMB Life. 2019.
8.Yang Y, Wang Y, Kong Y, Zhang X, Zhang H, Gang Y, et al. Carnosine prevents type 2 diabetes-induced osteoarthritis through the ROS/NF-κB pathway. Front Pharmacol. 2018;9:598.
9.Arellano Perez Vertti RD, Aguilar Muniz LS, Moran Martinez J, Gonzalez Galarza FF, Arguello Astorga R. Cartilage oligomeric matrix protein levels in type 2 diabetes associated with primary knee osteoarthritis patients. Genet Test Mol Biomarkers. 2019;23(1):16–22.
10.Adeyemi WJ, Olayaki LA. Additive and nonadditive effects of salmon calcitonin and omega-3 fatty acids on antioxidant, hematological and bone and cartilage markers in experimental diabetic-osteoarthritic rats. Chin J Physiol. 2019;62(3):108.
11.Juybari KB, Hosseinzadeh A, Sharifi AM. Protective effects of atorvastatin against high glucose-induced nuclear factor-κB activation in cultured C28I2 chondrocytes. J Recept Signal Transduct. 2019;39(1):1–8.
12.DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin. 2004;88(4):787–835.
13.Klip A, Marette A, Dimitrakoudis D, Ramlal T, Giacca A, Shi ZQ, et al. Effect of diabetes on glucoregulation: from glucose transporters to glucose metabolism in vivo. Diabetes Care. 1992;15(11):1747–66.
14.Veronese N, Cooper C, Reginster J-Y, Hochberg M, Branco J, Bruyère O, et al., editors. Type 2 diabetes mellitus and osteoarthritis. Seminars in arthritis and rheumatism; 2019: Elsevier
15.Daudt HM, van Mossel C, Scott SJ. Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework. BMC Med Res Methodol. 2013;13(1):48.
16.Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
17.Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.
18.Wittenauer R, Smith L, Aden K. Background paper 6.12 osteoarthritis. World Health Organisation. 2013.
19.Majjad A, Errahali Y, Toufik H, Djossou HJ, Ghassem M, Kasouati J, et al. Musculoskeletal disorders in patients with diabetes mellitus: a cross-sectional study. Int J Rheumatol. 2018;2018.
20.Duclos M. Osteoarthritis, obesity and type 2 diabetes: the weight of waist circumference. Ann Phys Rehabil Med. 2016;59(3):157–60.
21.Courties A, Sellam J. Osteoarthritis and type 2 diabetes mellitus: what are the links? Diabetes Res Clin Pract. 2016;122:198–206.
22.Neumann J, Hofmann FC, Heilmeier U, Ashmeik W, Tang K, Gersing AS, et al. Type 2 diabetes patients have accelerated cartilage matrix degeneration compared to diabetes free controls: data from the osteoarthritis initiative. Osteoarthr Cartil. 2018;26(6):751–61.
23.Courties A, Sellam J, Berenbaum F. Metabolic syndrome-associated osteoarthritis. Curr Opin Rheumatol. 2017;29(2):214–22.
24.Ribeiro M, de Figueroa PL, Blanco F, Mendes A, Carames B. Insulin decreases autophagy and leads to cartilage degradation. Osteoarthr Cartil. 2016;24(4):731–9.
25.Pritchard J, Papaioannou A, Tomowich C, Giangregorio L, Atkinson S, Beattie K, et al. Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone. Bone. 2013;54(1):76–82.
26.Chen Y, Huang Y-C, Yan CH, Chiu KY, Wei Q, Zhao J, et al. Abnormal subchondral bone remodeling and its association with articular cartilage degradation in knees of type 2 diabetes patients. Bone Res. 2017;5(1):17034.
27.Dubey N, Ningrum D, Dubey R, Deng Y-H, Li Y-C, Wang P, et al. Correlation between diabetes mellitus and knee osteoarthritis: a dry-to-wet lab approach. Int J Mol Sci. 2018;19(10):3021.
28.Luo S, Shi Q, Chen J, Wang H, Wu W, Zha Z. Expression and significance of MMPs in synovial fluid, serum and PBMC culture supernatant stimulated by LPS in osteoarthritis patients with or without diabetes. Exp Clin Endocrinol Diabetes. 2019;127(04):195–202.
29.Barrett KE, Barman SM, Boitano S, Brooks H. Ganong’s review of medical physiology. 23. NY: McGraw-Hill Medical; 2009.
30.Mobasheri A, Vannucci S, Bondy C, Carter S, Innes J, Arteaga M, et al. Glucose transport and metabolism in chondrocytes: a key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis. Histol Histopathol. 2002.
31.Hajiaghaalipour F, Khalilpourfarshbafi M, Arya A. Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus. Int J Biol Sci. 2015;11(5):508–24.
32.Rosa SC, Gonçalves J, Judas F, Mobasheri A, Lopes C, Mendes AF. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res Ther. 2009;11(3):R80.
33.Schett G, Kleyer A, Perricone C, Sahinbegovic E, Iagnocco A, Zwerina J, et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care. 2013;36(2):403–9.
34.Rosa S, Rufino A, Judas F, Tenreiro C, Lopes M, Mendes A. Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin. Osteoarthr Cartil. 2011;19(6):719–27.
35.Rufino AT, Rosa SC, Judas F, Mobasheri A, Lopes MC, Mendes AF. Expression and function of K (ATP) channels in normal and osteoarthritic human chondrocytes: possible role in glucose sensing. J Cell Biochem. 2013;114(8):1879–89.
36.McNulty AL, Stabler TV, Vail TP, McDaniel GE, Kraus VB. Dehydroascorbate transport in human chondrocytes is regulated by hypoxia and is a physiologically relevant source of ascorbic acid in the joint. Arthritis Rheum. 2005;52(9):2676–85.
37.Garcia-Carbonell R, Divakaruni AS, Lodi A, Vicente-Suarez I, Saha A, Cheroutre H, et al. Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol. 2016;68(7):1614–26.
38.Laiguillon M-C, Courties A, Houard X, Auclair M, Sautet A, Capeau J, et al. Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis. Osteoarthr Cartil. 2015;23(9):1513–22.
39.Wang C, Silverman RM, Shen J, O’Keefe RJ. Distinct metabolic programs induced by TGF-β1 and BMP2 in human articular chondrocytes with osteoarthritis. J Orthop Transl. 2018;12:66–73.
40.Yang X, Chen W, Zhao X, Chen L, Li W, Ran J, et al. Pyruvate kinase M2 modulates the glycolysis of chondrocyte and extracellular matrix in osteoarthritis. DNA Cell Biol. 2018;37(3):271–7.
Comments (0)